Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-25-000024
Filing Date
2025-08-07
Accepted
2025-08-07 09:21:09
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20250630.htm   iXBRL 10-Q 1065428
2 EX-10.1 exhibit101q22025.htm EX-10.1 124926
3 EX-10.2 exhibit102q22025.htm EX-10.2 120291
4 EX-31.1 exhibit311q22025.htm EX-31.1 10666
5 EX-31.2 exhibit312q22025.htm EX-31.2 10475
6 EX-32.1 exhibit321q22025.htm EX-32.1 5618
7 EX-32.2 exhibit322q22025.htm EX-32.2 5454
  Complete submission text file 0001012477-25-000024.txt   5623348

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20250630.xsd EX-101.SCH 32402
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20250630_cal.xml EX-101.CAL 63714
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20250630_def.xml EX-101.DEF 107009
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20250630_lab.xml EX-101.LAB 448705
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20250630_pre.xml EX-101.PRE 301890
74 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20250630_htm.xml XML 721145
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 251192045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)